The invention relates to a pharmaceutical combined preparation of LHRH analogues and anti-oestrogens having tissue-selective oestrogen activity and also to its use for the treatment of gynaecological disorders, especially for the treatment …
The invention relates to a pharmaceutical combined preparation of LHRH analogues and anti-oestrogens having tissue-selective oestrogen activity and also to its use for the treatment of gynaecological disorders, especially for the treatment …
The invention relates to a pharmaceutical combined preparation of LHRH analogues and anti-oestrogens having tissue-selective oestrogen activity and also to its use for the treatment of gynaecological disorders, especially for the treatme…
The invention relates to a pharmaceutical combined preparation of LHRH analogues and anti-oestrogens having tissue-selective oestrogen activity and also to its use for the treatment of gynaecological disorders, especially for the treatme…
The invention relates to a pharmaceutical combined preparation of LHRH analogues and anti-oestrogens having tissue-selective oestrogen activity and also to its use for the treatment of gynaecological disorders, especially for the treatment …
A combined pharmaceutical preparation contains LHRH-analogous substances and anti-estrogens with tissue-selective estrogenic effect. Also disclosed is the use of this combined pharmaceutical preparation to treat gynaecological disorders, in…
A combined pharmaceutical preparation contains LHRH-analogous substances and anti-estrogens with tissue-selective estrogenic effect. Also disclosed is the use of this combined pharmaceutical preparation to treat gynaecological disorders, in…